Skip to content

AtriCure ATRC EV / sales

EV / sales at other companies

Abbott logo
AbbottABT
4.6×-1.0×
Johnson & Johnson logo
Johnson & JohnsonJNJ
6.5×+1.8×
Boston Scientific logo
Boston ScientificBSX
-1.5×
Medtronic logo
MedtronicMDT
3.6×-0.4×
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
1,873.1×
Artivion logo
ArtivionAORT
4.3×+0.8×

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-7.9%
Enterprise value$1.36B-11.2%
P/S2.6×-0.6×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Calculated from AtriCure’s reported figures.

Based on the most recent quarter.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's EV / sales?
AtriCure (ATRC) reported EV / sales of 2.4× in Q1 2026.
How has AtriCure's EV / sales changed year-over-year?
AtriCure's EV / sales decreased by 24.5% year-over-year, from 3.2× to 2.4×.
What is the long-term trend for AtriCure's EV / sales?
Over 5 years (2020 to 2025), AtriCure's EV / sales has grown at a -22.5% compound annual growth rate (CAGR), from 12.5× to 3.5×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.